UnitedHealth Group (NYSE: UNH) recently reported its Q3 results, with revenues and earnings exceeding our expectations.

UnitedHealth Group's stock fell 8.1% despite beating Q3 estimates due to conservative 2024 and 2025 EPS guidance. Find out ...

The UNH stock performance is affected by management’s full-year 2024 outlook of $15.50 to $15.75 per share in net income, ...

Is UnitedHealth stock a buy, sell or hold? Heading into Tuesday's trading, UnitedHealth Group stock was up 16.4% on a total ...

UnitedHealth (UNH) stock fell amid rising medical costs in its insurance unit even as the company posted better-than-expected ...

We recently compiled a list of the Jim Cramer is Talking About These 14 Stocks Before Earnings. In this article, we are going ...

We recently compiled a list of 10 Safe Stocks To Invest In For The Long Term in 2024. In this article, we will look at where ...

Mizuho Securities analyst Ann Hynes has assigned their bullish stance on UNH stock, giving a Buy rating today. Ann Hynes has given her Buy ...

Elevance Health Inc.'s stock tumbled 13% Thursday and weighed on rivals after the health insurer's third-quarter profit fell short of estimates amid "unprecedented" challenges in the Medicaid business ...

UnitedHealth (UNH) delivered earnings and revenue surprises of 1.85% and 1.31%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?

Oppenheimer analyst Michael Wiederhorn maintained a Buy rating on UnitedHealth (UNH – Research Report) today and set a price target of ...

UnitedHealth earnings topped forecasts, but the Dow Jones member lowered the top end of its full-year outlook.